The Pre-Clinical Animal Model in the Translational Research of Interventional Cardiology

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 373-383

  Suzuki, Yoriyasu ^a,b   Yeung, Alan C ^a   Ikeno, Fumiaki ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nagoya Heart Center   (Japan)

Author keywords

animal model; cardiovascular intervention; pre clinical study

Indexed keywords

PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ANIMAL MODEL; BASIC RESEARCH; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; DEVICE; DRUG ELUTING STENT; EXPERIMENTAL THERAPY; HEALTH STATUS; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CORONARY ARTERY DISEASE; DISEASE MODEL; DRUG SCREENING; EVIDENCE BASED MEDICINE; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; SWINE;

ANIMALS; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; SWINE;

EID: 65549117086     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.03.004     Document Type: Review

References (87)

1. Serruys P.W., Degertekin M., Tanabe K., et al., RAVEL Study Group. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106 (2002) 798-803
2. Sousa J.E., Costa M.A., Abizaid A., et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 107 (2003) 24-27
3. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
4. Park S.J., Shim W.H., Ho D.S., et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 348 (2003) 1537-1545
5. Gallo R., Padurean A., Jayaraman T., et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99 (1999) 2164-2170
6. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104 (2001) 1188-1193
7. Teirstein P.S. Living the dream of no restenosis. Circulation 104 (2001) 1996-1998
8. Heldman A.W., Cheng L., Jenkins G.M., et al. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis. Circulation 103 (2001) 2289-2295
9. Schwartz R.S., Edelman E.R., Carter A., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
10. Kalinowski M., Alfke H., Bergen S., Klose K.J., Barry J.J., and Wagner H.J. Comparative trial of local pharmacotherapy with L-arginine, r-hirudin, and molsidomine to reduce restenosis after balloon angioplasty of stenotic rabbit iliac arteries. Radiology 219 (2001) 716-723
11. Nagae T., Aizawa K., Uchimura N., et al. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit intimal hyperplasia in balloon-injured rabbit arteries. Lasers Surg Med 28 (2001) 381-388
12. Kanamasa K., Otani N., Ishida N., Inoue Y., Morii H., and Ishikawa K. A 7-day administration of tPA or heparin in the prevention of intimal hyperplasia following vascular injury in atherosclerotic rabbits. J Interv Cardiol 15 (2002) 191-195
13. Schwartz R.S., Murphy J.G., Edwards W.D., Camrud A.R., Vliestra R.E., and Holmes D.R. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 82 (1990) 2190-2200
14. Schwartz R.S., Huber K.C., Murphy J.G., et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 19 (1992) 267-274
15. Schwartz R.S., Holder D.J., Holmes D.R., et al. Neointimal thickening after severe coronary artery injury is limited by a short-term administration of a factor Xa inhibitor. Results in a porcine model. Circulation 93 (1996) 1542-1548
16. Huber K.C., Schwartz R.S., Edwards W.D., et al. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J 125 (1993) 695-701
17. Schwartz R.S., Edelman E.R., Carter A., et al. Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation 110 (2004) 2498-2505
18. Ikeno F., Buchbinder M., and Yeung A.C. Novel stent and delivery systems for the treatment of bifurcation lesions: porcine coronary artery model. Cardiovasc Revasc Med 8 (2007) 38-42
19. Ikeno F., Inagaki K., Rezaee M., and Mochly-Rosen D. Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage. Cardiovasc Res 73 (2007) 699-709
20. Suzuki Y., Lyons J.K., Yeung A.C., and Ikeno F. In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk. Catheter Cardiovasc Interv 71 (2008) 100-107
21. Suzuki Y., Lyons J.K., Yeung A.C., and Ikeno F. The porcine restenosis model using thermal balloon injury: comparison with the model by coronary stenting. J Invasive Cardiol 20 (2008) 142-146
22. Schwartz R.S., Edelman E.R., Virmani R., et al. Drug-eluting stents in preclinical studies; updated consensus recommendations for preclinical evaluation. Circulation Cardiovasc Interv 1 (2008) 143-153
23. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H., and Leon M.B. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31 (1998) 224-230
24. Taylor A.J., Gorman P.D., Kenwood B., Hudak C., Tashko G., and Virmani R. A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model. Catheter Cardiovasc Interv 53 (2001) 420-425
25. Tanner F.C., Boehm M., Akyurek L.M., et al. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Circulation 101 (2000) 2022-2025
26. Sun J., Marx S.O., Chen H.J., Poon M., Marks A.R., and Rabbani L.E. Role for p27(Kip1) in vascular smooth muscle cell migration. Circulation 103 (2001) 2967-2972
27. Vinals F., Chambard J.C., and Pouyssegur J. p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation. J Biol Chem 274 (1999) 26776-26782
28. Abal M., Andreu J.M., and Barasoain I. Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. Curr Cancer Drug Targets 3 (2003) 193-203
29. Carter A.J., Laird J.R., Farb A., Kufs W., Wortham D.C., and Virmani R. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 24 (1994) 1398-1405
30. Edelman E.R., and Rogers C. Pathobiologic responses to stenting. Am J Cardiol 81 (1998) 4E-6E
31. Virmani R., Kolodgie F.D., Farb A., and Lafont A. Drug eluting stents: are human and animal studies comparable?. Heart 89 (2003) 133-138
32. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
33. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
34. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
35. Nakazawa G., Finn A.V., John M.C., Kolodgie F.D., and Virmani R. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents. Am J Cardiol 100 (2007) 36M-44M
36. OrbusNeich. Genous. [online images]. http://www.orbusneich.com/genous/invivo/animation/?PHPSESSID=6ad47ba6db4b3d91788bd72420b070fc Accessed April 12, 2009
37. Slottow T.L., Pakala R., Okabe T., et al. Optical coherence tomography and intravascular ultrasound imaging of bioabsorbable magnesium stent degradation in porcine coronary arteries. Cardiovasc Revasc Med 9 (2008) 248-254
38. Staab M.E., Srivatsa S.S., Lerman A., et al. Arterial remodeling after experimental percutaneous injury is highly dependent on adventitial injury and histopathology. Int J Cardiol 58 (1997) 31-40
39. Schapira K., Heeneman S., and Daemen M.J. Animal models to study plaque vulnerability. Curr Pharm Des 13 (2007) 1013-1020
40. Fuster V., Moreno P.R., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46 (2005) 937-954
41. Nakamura M., Abe S., and Kinukawa N. Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II. Atherosclerosis 128 (1997) 149-156
42. Eitzman D.T., Westrick R.J., Xu Z., Tyson J., and Ginsburg D. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20 (2000) 1831-1834
43. von der Thusen J.H., van Vlijmen B.J., Hoeben R.C., et al. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation 105 (2002) 2064-2070
44. Granada J.F., Moreno P.R., Burke A.P., Schulz D.G., Raizner A.E., and Kaluza G.L. Endovascular needle injection of cholesteryl linoleate into the arterial wall produces complex vascular lesions identifiable by intravascular ultrasound: early development in a porcine model of vulnerable plaque. Coron Artery Dis 16 (2005) 217-224
45. Granada J.F., Wallace-Bradley D., Win H.K., et al. In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol 27 (2007) 387-393
46. Virmani R., and Nakazawa G. Animal models and virtual histology. Arterioscler Thromb Vasc Biol 27 (2007) 1666 author reply 1667-8
47. Shiomi M., Ito T., Yamada S., Kawashima S., and Fan J. Correlation of vulnerable coronary plaques to sudden cardiac events. Lessons from a myocardial infarction-prone animal model (the WHHLMI rabbit). J Atheroscler Thromb 11 (2004) 184-189
48. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108 (2003) 1664-1672
49. Faber B.C., Cleutjens K.B., Niessen R.L., et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ Res 89 (2001) 547-554
50. Ng W., Chen W.-H., Lee P.-Y., and Lau C.-P. Initial experience and safety in the treatment of chronic total coronary occlusions with a new optical coherent reflectometry-guided radiofrequency ablation guidewire. Am J Cardiol 92 (2003) 732-734
51. Orlic D., Stankovic G., Sangiorgi G., et al. Preliminary experience with the Frontrunner coronary catheter: novel device dedicated to mechanical revascularization of chronic total occlusions. Catheter Cardiovasc Interv 64 (2005) 146
52. Elzinga W.E. Ameroid constrictor: uniform closure rates and a calibration procedure. J Appl Physiol 27 (1969) 419-421
53. Strauss B.H., Goldman L., Qiang B., et al. Collagenase plaque digestion for facilitating guide wire crossing in chronic total occlusions. Circulation 108 (2003) 1259-1262
54. Strauss B.H., Segev A., Wright G.A., et al. Microvessels in chronic total occlusions: pathways for successful guidewire crossing?. J Interv Cardiol 18 (2005) 425-436
55. Nikol S., Armeanu S., Engelmann M.G., et al. Evaluation of endovascular techniques for creating a porcine femoral artery occlusion model. J Endovasc Ther 8 (2001) 401-407
56. Katsuragawa M., Fujiwara H., Miyamae M., and Sasayama S. Histologic studies in percutaneous transluminal coronary angioplasty for chronic total occlusion: comparison of tapering and abrupt types of occlusion and short and long occluded segments. J Am Coll Cardiol 21 (1993) 604-611
57. Srivatsa S.S., Edwards W.D., Boos C.M., et al. Histologic correlates of angiographic chronic total coronary artery occlusions: influence of occlusion duration on neovascular channel patterns and intimal plaque composition. J Am Coll Cardiol 29 (1997) 955-963
58. Suzuki Y., Lyons J.K., Yeung A.C., and Ikeno F. The porcine restenosis model using thermal balloon injury: comparison with the model by coronary stenting. J Invasive Cardiol 20 (2008) 142-146
59. Tanguay J.F., Zidar J.P., Phillips H.R., and Stack R.S. Current status of biodegradable stents. Cardiol Clin 12 (1994) 699-713
60. Prosser L., Agrawal C.M., Polan J., Elliott J., Adams D.G., and Bailey S.R. Implantation of oxygen enhanced, three-dimensional microporous L-PLA polymers: a reproducible porcine model of chronic total coronary occlusion. Catheter Cardiovasc Interv 67 (2006) 412-416
61. Suzuki K., Saito N., Zhang G., et al. Development of a novel calcified total occlusion model in porcine coronary arteries. J Invasive Cardiol 20 (2008) 296-301
62. Suzuki Y., Oyane A., Ikeno F., Lyons J.K., and Yeung A.C. Development of animal model for calcified chronic total occlusion (cto). Catheter Cardiovasc Interv (2009) Feb 2 [E-pub ahead of print]
63. Bonhoeffer P., Boudjemline Y., Saliba Z., et al. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation 102 (2000) 813-816
64. Cribier A., Eltchaninoff H., Bash A., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002) 3006-3008
65. Fann J.I., Chronos N., Rowe S.J., et al. Evolving strategies for the treatment of valvular heart disease: preclinical and clinical pathways for percutaneous aortic valve replacement. Catheter Cardiovasc Interv 71 (2008) 434-440
66. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24 (2003) 1231-1243
67. Cribier A., Eltchaninoff H., Tron C., et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 43 (2004) 698-703
68. Grube E., Laborde J.C., Gerckens U., et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114 (2006) 1616-1624
69. Vahanian A., Alfieri O., Al-Attar N., et al., European Association of Cardio-Thoracic Surgery, European Society of Cardiology, European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29 (2008) 1463-1470
70. Otto C.M. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 345 (2001) 740-746
71. Gillinov A.M., and Liddicoat J.R. Percutaneous mitral valve repair. Semin Thorac Cardiovasc Surg 18 (2006) 115-121
72. Feldman T., Wasserman H.S., Herrmann H.C., et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 46 (2005) 2134-2140
73. Alfieri O., Elefteriades J.A., Chapolini R.J., et al. Novel suture device for beating-heart mitral leaflet approximation. Ann Thorac Surg 74 (2002) 1488-1493
74. Liddicoat J.R., Mac Neill B.D., Gillinov A.M., et al. Percutaneous mitral valve repair: a feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv 60 (2003) 410-416
75. Kaye D.M., Byrne M., Alferness C., and Power J. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 108 (2003) 1795-1797
76. Maniu C.V., Patel J.B., Reuter D.G., et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol 44 (2004) 1652-1661
77. Daimon M., Shiota T., Gillinov A.M., et al. Percutaneous mitral valve repair for chronic ischemic mitral regurgitation: a real-time three-dimensional echocardiographic study in an ovine model. Circulation 111 (2005) 2183-2189
78. Feldman T. Percutaneous valve repair and replacement: challenges encountered, challenges met, challenges ahead. Circulation 113 (2006) 771-773
79. Webb J.G., Harnek J., Munt B.I., et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation 113 (2006) 851-855
80. Komamura K., Shannon R.P., Pasipoularides A., et al. Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure. J Clin Invest 89 (1992) 1825-1838
81. Yamamoto K., Burnett Jr. J.C., Meyer L.M., Sinclair L., Stevens T.L., and Redfield M.M. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol 271 (1996) R1529-R1534
82. Gorman R.C., McCaughan J.S., Ratcliffe M.B., et al. Pathogenesis of acute ischemic mitral regurgitation in three dimensions. J Thorac Cardiovasc Surg 109 (1995) 684-693
83. Nakai T., Lesh M.D., Gerstenfeld E.P., Virmani R., Jones R., and Lee R.J. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 105 (2002) 2217-2222
84. Chiam P.T., and Ruiz C.E. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation. J Invasive Cardiol 20 (2008) E109-E113
85. Schwerzmann M., Windecker S., Wahl A., et al. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 90 (2004) 186-190
86. Hara H., Virmani R., Ladich E., et al. Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts. Catheter Cardiovasc Interv 69 (2007) 266-273
87. Eltchaninoff H., Zajarias A., Tron C., et al. Transcatheter aortic valve implantation: technical aspects, results and indications. Arch Cardiovasc Dis 101 (2008) 126-132